You are here : Home >Salivax™  > Hep B

Salivax™ -HBV 

Catalog No.:

Currently undergoing clinical trials.

The Disease

Hepatitis B is an infection of liver caused by the hepatitis B virus. If undetected and untreated it may lead to liver cirrhosis and cancer. Worldwide, one in twelve persons are estimated to be living with viral hepatitis and every year 1 million people around the world die because of viral hepatitis. Many people infected with viral hepatitis are unaware of their status and as a result, may unknowingly transmit the infection to others.


Salivax™ -HBV (under development) is an immunoassay intended for use in qualitative detection of IgG antibodies to the Hepetitis B- core antigen (anti-IgG antibodies) in human saliva. It is designed to be used as a “point of care” test, by the medical professionals in the health care facilities. Salivax™- HBV makes full use of the strengths of the Salivax™ platform with its unique saliva filtration and purification system to provide a high yield of antibodies.A positive test will be indicated by two pink dots in the well of the test device. A negative test will have only one control dot visible. The test takes about fifteen minutes from the point of application of sample to the device.


Salivax™-HBV is intended for screening of subjects who may have been exposed to the hepatits B virus. All subjects testing positive on Salivax™ should be retested with a confirmatory standard.


Like all Salivax™ products, Salivax™-HBV is non-invasive, easy to use, rapid, reliable and accurate. It requires no specialized equipment or specially trained personnel. It doesn't expose health care workers to potentially infectious body fluids. The simplicity and lack of necessity for vacuum tubes, centrifuge and refrigeration makes Salivax™-HBV very inexpensive to use especially in public health, military and home applications. The Salivax™ tests have an added ease of storage being stable at virtually all ambient temperatures.


In our laboratory ImmunoScience has analyzed different antigens of the virus to detect antibodies in human body fluids using various immunoassay formats. Consistently, and with high sensitivity Salivax-HBV detects antibodies to the hep B core antigen in human saliva. Studies show that the detection of hep B core antibodies is a clear indicator of infection. In a small clinical study, the Salivax-HBV test results demonstrate an accuracy comparable to high end instruments to analyze immunoassays and diagnose infection.